«FOSCARNET»に関連する英語の本
以下の図書目録から
foscarnetの使いかたを見つけましょう。
foscarnetに関する本と英語文献で使われた文脈を提供するための簡単な抜粋文。
1
Clinical Infectious Diseases: A Practical Approach
Indications The only approved indications for foscarnet are CMV retinitis and
mucocutaneous acyclovir-resistant HSV infections in the im- munocompromised.
In light of improved survival in patients treated with foscarnet rather than
ganciclovir.
TK-deficient, acyclovir- resistant herpesviruses remain sensitive to foscarnet.
Foscarnet has been used successfully to treat severe mucocutaneous HSV
infections caused by acyclovir-resistant HSV-2 (95). Foscarnet also inhibits
influenza A ...
Sherwood L. Gorbach, John G. Bartlett, Neil R. Blacklow, 2004
3
Blood and Marrow Stem Cell Transplantation: Principles, ...
Although approved by the FDA only to treat CMV retinitis, foscarnet is frequently
used in BMT patients in a variety of ways. In general, foscarnet is used as second
-line therapy in patients with viral infections refractory to conventional therapy ...
Marie Bakitas Whedon, Debra Wujcik, 1997
4
The Antimicrobial Drugs
foscarnet and phosphate deposition in bone and cartilage. In mice about 30% of
the foscarnet is retained in bone and cartilage. Foscarnet is not metabolized to
any significant extent after intravenous administration, and as much as 88% of a ...
Eric Michael Scholar, William B. Pratt, 2000
5
Psychiatric Side Effects of Prescription and ...
Foscarnet Foscarnet Foscarnet Foscavir® General Foscarnet has a high rate of
neuropsychiatric complications. Foscarnet may cause generalized seizures in 7
%- 10% of patients, malaise in 5% or more, fatigue in 5% or more, mood changes
...
Thomas Markham Brown, Alan Stoudemire, 1998
Foscarnet is an antiviral agent with promising results against herpes viruses.
Foscarnet is a pyrophosphate analogue that interferes with viral replication by
binding to a site on the herpes virus DNA polymerase or human
immunodeficiency ...
Ellis D. Avner, William E. Harmon, Patrick Niaudet, 2009
7
Clinical Infectious Disease
Fomivirsen injection may be considered in situations in which conventional
therapy, including systemic or intravitreal ganciclovir, foscarnet, or cidofo- vir, has
failed or is contraindicated. Induction therapy consists of 330 μg by intravitreal ...
8
Clinical Nephrotoxins: Renal Injury from Drugs and Chemicals
These crystals have had an appearance similar to that of crystalline foscarnet. In
addition to trisodium foscarnet, crystals have also been identified as being mixed
sodium—calcium and rarely pure calcium salts of foscarnet [63, 64].
William M. Bennett, Marc E. de Broe, Gilbert Deray, 2008
9
Koda-Kimble and Young's Applied Therapeutics: The Clinical ...
Cidofovir appears to be as efficacious as foscarnet and ganciclovir in the
treatment of CMV retinitis, but limited comparative studies have been performed.
Finally, the efficacy of cidofovir in the treatment of extraocular CMV (e.g., GI
disease, ...
Brian K. Alldredge, Robin L. Corelli, Michael E. Ernst, 2012
10
Smolin and Thoft's The Cornea: Scientific Foundations and ...
Structure Foscarnet (phosphonoformic acid; PFA; Foscavir) is a pyrophosphate
derivative of phosphonoacetic acid. It differs from all previously discussed
antivirals in that it is not a nucleoside analog (282,283). It is FDA approved for
treatment ...
Gilbert Smolin, Charles Stephen Foster, Dimitri T. Azar, 2005
用語«FOSCARNET»を含むニュース項目
国内外の報道機関が語った内容や、次のニュース項目の文脈から
foscarnetという用語がどのように使われているかを調べてみましょう。
Cookies on Pharmiweb.Com
The major drugs prescribed for the treatment of CMV infections are ganciclovir valganciclovir foscarnet and cidofovir. The CMV therapeutics ... «PharmiWeb.com, 6月 15»
Chimerix's (CMRX) CEO Michelle Berrey on Q1 2015 Results …
... of the currently available antiviral such as ganciclovir and foscarnet, which are associated with bone marrow suppression and kidney toxicity. «Seeking Alpha, 5月 15»
Research and Markets: Human Papillomavirus and …
The major drugs prescribed for the treatment of CMV infections are ganciclovir, valganciclovir, foscarnet, and cidofovir. The CMV therapeutics ... «Business Wire, 4月 15»
Antivirals improve CMV pneumonia outcomes after HCT
In the event of marrow suppression, Foscavir (foscarnet sodium, Clinigen) was given as a substitute. In the late 1980s, adjunct therapy with ... «Healio, 3月 15»
Adoptive T-cell immunotherapy for ganciclovir-resistant CMV …
Alternative treatments are limited: foscarnet is the first-line for the treatment of GRCMV. Although some patients treated with foscarnet have ... «Nature.com, 3月 15»
Epidemiology of Infections After Solid Organ and Hematopoietic …
Streptococcus pneumonia and other encapsulated bacteria, Valganciclovir (Valcyte, Genentech) or foscarnet (prophylaxis or preemptive therapy) to prevent ... «Infectious Disease Special Edition, 3月 15»
Exploring the dynamics of the herpesvirus family
The key argument for pre-emptive therapy is that with the existing drugs (ie, valganciclovir, foscarnet, cidofovir), prophylaxis has never been shown in a ... «Healio, 1月 15»
Chimerix Ready to Go Antiviral
... superiority trial comparing brincidofovir prophylaxis to the current standard of care of preemptive treatment either with ganciclovir or foscarnet ... «Barron's, 1月 15»
Chimerix's (CMRX) CEO Michelle Berrey Hosts R&D Update …
... virus reactivation that we have to give some kind of therapy with Rituximab, Ganciclovir, Foscarnet, IV Cidofovir and or reducing suppression. «Seeking Alpha, 10月 14»
Clinigen Group plc Receives FDA's First Ever Drug Shortage …
Foscavir® (foscarnet sodium) injection, part of Clinigen's anti-infectives portfolio, is indicated for the treatment of cytomegalovirus (CMV) retinitis ... «MarketWatch, 9月 14»
